HNRNPA2B1 and neurodegenerative disease: Combination of NMR, in vitro and in vivo assays reveal that phosphorylation of the RNA binding protein hnRNPA2, linked to protein aggregation diseases and a component of transport granules, reduces liquid‐liquid phase separation and protein aggregation pointing to new strategies for the treatment of neurodegenerative diseases.